Abstract:TMEM56 is specifically and dynamically expressed in erythroid lineage. By inducing the erythroid differentiation from human primary haematopoietic stem and progenitor CD34+ cells derived from umbilical cord blood, we found that TMEM56 is vital for erythroid differentiation. Using the lineage‐specific Tmem56 knockout mouse models, we further revealed that a deficiency in Tmem56 leads to a decrease in erythroid progenitors, underscoring its role in the early stages of erythropoiesis. Crucially, the absence of TMEM56 impairs haem biosynthesis, triggers a cell cycle arrest and thus disrupts the normal progression of erythroid cells. Taken together, our study provides novel insights into the role of TMEM56 during erythropoiesis and suggests that TMEM56 might serve as a potential target for erythroid disorders. Summary TMEM56, a gene coding a transmembrane protein, is abundantly expressed in erythroid cells. Despite this, its role in erythropoiesis has not been well characterized. In this study, we sought to clarify the function of TMEM56 in erythroid development, focusing specifically on its involvement in haem biosynthesis and cell cycle progression. To do this, we used CD34+ haematopoietic stem cells derived from umbilical cord blood and differentiated them into erythroid cells in an ex vivo model. Our results indicate that the loss of TMEM56 disrupts haem biosynthesis and impairs erythroid differentiation. Furthermore, deletion of Tmem56 in the erythroid lineage in murine models using erythropoietin receptor (EpoR)‐Cre revealed defects in erythroid progenitors within the bone marrow under both normal conditions and during haemolytic anaemia. These observations underscore the regulatory role of TMEM56 in maintaining erythroid lineage homeostasis. Taken together, our results unveil a previously unrecognized function of TMEM56 in erythroid differentiation and suggest its potential as an unfounded target for therapeutic strategies in the treatment of erythropoietic disorders.

Serine Hydroxymethyltransferase 2 Deficiency in the Hematopoietic System Disrupts Erythropoiesis and Induces Anemia in Murine Models

Heme-Regulated Eif2 Alpha Kinase (Hri) Is Required For Translational Regulation And Survival Of Erythroid Precursors In Iron Deficiency

Mitochondrial serine catabolism safeguards maintenance of the hematopoietic stem cell pool in homeostasis and injury

Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression

SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice

MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction

Protein Arginine Methyltransferase 1 is Required for Maintenance of Normal Adult Hematopoiesis

Setd2 is Critical for Maintaining Hematopoietic Homeostasis

SETD2 is Essential for Terminal Differentiation of Erythroblasts During Fetal Erythropoiesis.

Quantitative Analysis of Murine Terminal Erythroid Differentiation in Vivo: Novel Method to Study Normal and Disordered Erythropoiesis

TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis

Shp2 and Pten Have Antagonistic Roles in Myeloproliferation but Cooperate to Promote Erythropoiesis in Mammals

Dynamic changes in murine erythropoiesis from birth to adulthood: implications for the study of murine models of anemia

Serine Hydroxymethyltransferase 1 and 2: Gene Sequence Variation and Functional Genomic Characterization

<i>IDH1</i> mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis

A mutation in Sec15l1 causes anemia in hemoglobin deficit ( hbd ) mice

Setd2 Deficiency Impairs Hematopoietic Stem Cell Self-Renewal and Causes Malignant Transformation

Sfxn1 is Essential for Erythrocyte Maturation Via Facilitating Hemoglobin Production in Zebrafish

Mitochondrial ATP transporter Ant2 depletion impairs erythropoiesis and B lymphopoiesis

Aberrant rRNA 2'-O-Methylation Causes Bone Marrow Failure and Defective Immune Function

Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway